These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 33466323)

  • 1. Human Plasma Metabolomics for Biomarker Discovery: Targeting the Molecular Subtypes in Breast Cancer.
    Díaz-Beltrán L; González-Olmedo C; Luque-Caro N; Díaz C; Martín-Blázquez A; Fernández-Navarro M; Ortega-Granados AL; Gálvez-Montosa F; Vicente F; Pérez Del Palacio J; Sánchez-Rovira P
    Cancers (Basel); 2021 Jan; 13(1):. PubMed ID: 33466323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting dynamic response to neoadjuvant chemotherapy in breast cancer: a novel metabolomics approach.
    Díaz C; González-Olmedo C; Díaz-Beltrán L; Camacho J; Mena García P; Martín-Blázquez A; Fernández-Navarro M; Ortega-Granados AL; Gálvez-Montosa F; Marchal JA; Vicente F; Pérez Del Palacio J; Sánchez-Rovira P
    Mol Oncol; 2022 Jul; 16(14):2658-2671. PubMed ID: 35338693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pattern of Local Recurrence and Distant Metastasis in Breast Cancer By Molecular Subtype.
    Wu X; Baig A; Kasymjanova G; Kafi K; Holcroft C; Mekouar H; Carbonneau A; Bahoric B; Sultanem K; Muanza T
    Cureus; 2016 Dec; 8(12):e924. PubMed ID: 28090417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human plasma metabolomics for identifying differential metabolites and predicting molecular subtypes of breast cancer.
    Fan Y; Zhou X; Xia TS; Chen Z; Li J; Liu Q; Alolga RN; Chen Y; Lai MD; Li P; Zhu W; Qi LW
    Oncotarget; 2016 Mar; 7(9):9925-38. PubMed ID: 26848530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative proteomics revealed novel proteins associated with molecular subtypes of breast cancer.
    Suman S; Basak T; Gupta P; Mishra S; Kumar V; Sengupta S; Shukla Y
    J Proteomics; 2016 Oct; 148():183-93. PubMed ID: 27498393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A plasma metabolomic signature discloses human breast cancer.
    Jové M; Collado R; Quiles JL; Ramírez-Tortosa MC; Sol J; Ruiz-Sanjuan M; Fernandez M; de la Torre Cabrera C; Ramírez-Tortosa C; Granados-Principal S; Sánchez-Rovira P; Pamplona R
    Oncotarget; 2017 Mar; 8(12):19522-19533. PubMed ID: 28076849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure patterns according to molecular subtype in patients with invasive breast cancer following postoperative adjuvant radiotherapy: long-term outcomes in contemporary clinical practice.
    Lim YJ; Lee SW; Choi N; Kwon J; Eom KY; Kang E; Kim EK; Kim SW; Kim JH; Kim YJ; Kim SH; Park SY; Kim JS; Kim IA
    Breast Cancer Res Treat; 2017 Jun; 163(3):555-563. PubMed ID: 28315066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic reprogramming enables the auxiliary diagnosis of breast cancer by automated breast volume scanner.
    Liu J; Zhou Y; Liu H; Ma M; Wang F; Liu C; Yuan Q; Wang H; Hou X; Yin P
    Front Oncol; 2022; 12():939606. PubMed ID: 36313729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of Pancreatic Adenocarcinoma Biomarkers by Untargeted Metabolomics.
    Martín-Blázquez A; Jiménez-Luna C; Díaz C; Martínez-Galán J; Prados J; Vicente F; Melguizo C; Genilloud O; Pérez Del Palacio J; Caba O
    Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32325731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolomic profile of children with recurrent respiratory infections.
    Bozzetto S; Pirillo P; Carraro S; Berardi M; Cesca L; Stocchero M; Giordano G; Zanconato S; Baraldi E
    Pharmacol Res; 2017 Jan; 115():162-167. PubMed ID: 27888158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma Metabolic Profiling of Human Thyroid Nodules by Gas Chromatography-Mass Spectrometry (GC-MS)-Based Untargeted Metabolomics.
    Abooshahab R; Hooshmand K; Razavi SA; Gholami M; Sanoie M; Hedayati M
    Front Cell Dev Biol; 2020; 8():385. PubMed ID: 32612989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Significance of Progesterone Receptor Expression in Estrogen-Receptor Positive, HER2-Negative, Node-Negative Invasive Breast Cancer With a Low Ki-67 Labeling Index.
    Ono M; Tsuda H; Yoshida M; Shimizu C; Kinoshita T; Tamura K
    Clin Breast Cancer; 2017 Feb; 17(1):41-47. PubMed ID: 27477822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer detection using targeted plasma metabolomics.
    Jasbi P; Wang D; Cheng SL; Fei Q; Cui JY; Liu L; Wei Y; Raftery D; Gu H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jan; 1105():26-37. PubMed ID: 30562627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolomic profiling in colorectal cancer: opportunities for personalized medicine.
    Zheng X; Xie G; Jia W
    Per Med; 2013 Sep; 10(7):741-755. PubMed ID: 29768755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A quantitative multimodal metabolomic assay for colorectal cancer.
    Farshidfar F; Kopciuk KA; Hilsden R; McGregor SE; Mazurak VC; Buie WD; MacLean A; Vogel HJ; Bathe OF
    BMC Cancer; 2018 Jan; 18(1):26. PubMed ID: 29301511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma metabolomic signatures of breast cancer.
    Xu Y; Zhao B; Xu Z; Li X; Sun Q
    Front Med (Lausanne); 2023; 10():1148542. PubMed ID: 37588002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative tissue proteomic investigation of invasive ductal carcinoma of breast with luminal B HER2 positive and HER2 enriched subtypes towards potential diagnostic and therapeutic biomarkers.
    Pendharkar N; Gajbhiye A; Taunk K; RoyChoudhury S; Dhali S; Seal S; Mane A; Abhang S; Santra MK; Chaudhury K; Rapole S
    J Proteomics; 2016 Jan; 132():112-30. PubMed ID: 26642762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical Subtypes of Breast Cancer: Correlation with Clinicopathological and Radiological Factors.
    Sohn YM; Han K; Seo M
    Iran J Radiol; 2016 Oct; 13(4):e31386. PubMed ID: 27895868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multipronged quantitative proteomics reveals serum proteome alterations in breast cancer intrinsic subtypes.
    Gajbhiye A; Dabhi R; Taunk K; Jagadeeshaprasad MG; RoyChoudhury S; Mane A; Bayatigeri S; Chaudhury K; Santra MK; Rapole S
    J Proteomics; 2017 Jun; 163():1-13. PubMed ID: 28495502
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.